The anti-malaria medication artesunate could be a potential treatment of Sjögren’s syndrome, a study suggested. In mouse and cellular models,…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
Higher-than-normal blood levels of uric acid, a body waste product, significantly raise the risk of hypertension among people with primary…
Levels of the inflammatory molecule IL-7 were higher in the blood of people with Sjögren’s syndrome compared with healthy…
Researchers have developed a quick, noninvasive way of collecting tear fluid and analyzing the proteins in it — an approach…
People with Sjögren’s syndrome may be at a higher risk of developing multiple types of cancer, according to a recent…
A research team in Japan has developed three-dimensional (3D) “mini organs” from human stem cells to model the lacrimal glands,…
Levels of the chemical messenger CCL28 are reduced in the blood of people with primary and secondary Sjögren’s syndrome,…
Intense pulsed light therapy along with meibomian gland expression (IPL-MGX) significantly eased dry eye symptoms and improved eye health…
NYU Langone Health is joining with a National Institutes of Health (NIH) sponsored program aimed at understanding disease mechanisms…
Fatigue had the biggest impact on daily activities among people with primary Sjögren’s syndrome and was one of a number…